Jump to content

Pages with the fewest revisions

Pharmacopedia
BrowseCategoriesLog in

Showing below up to 50 results in range #501 to #550.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. USLegal:DEA Schedule III (2 revisions)
  2. Esomeprazole (2 revisions)
  3. Effect:Dependence / misuse (2 revisions)
  4. Problem:Fever (2 revisions)
  5. Methylprednisolone (2 revisions)
  6. Effect:Hyponatremia / SIADH (2 revisions)
  7. Problem:Multiple Sclerosis (2 revisions)
  8. Hydralazine (2 revisions)
  9. Effect:Visual stretching (2 revisions)
  10. Problem:Acute Stress Disorder (2 revisions)
  11. Metronidazole (2 revisions)
  12. Effect:Memory enhancement (2 revisions)
  13. Problem:Irritable Bowel Syndrome (2 revisions)
  14. Clobetasol (2 revisions)
  15. Effect:Novelty enhancement (2 revisions)
  16. Problem:Vertigo (2 revisions)
  17. Effect:Thought connectivity (2 revisions)
  18. Problem:Excessive daytime sleepiness in shift-work disorder (2 revisions)
  19. Effect:Focus intensification (2 revisions)
  20. Problem:Constipation (2 revisions)
  21. Penicillin G (2 revisions)
  22. Solifenacin (2 revisions)
  23. Effect:Extrapyramidal effects (2 revisions)
  24. Problem:Nightmares (2 revisions)
  25. Amlodipine (2 revisions)
  26. Losartan (2 revisions)
  27. Effect:Increased sense of humor (2 revisions)
  28. Problem:Postural Orthostatic Tachycardia Syndrome (2 revisions)
  29. Aspirin (2 revisions)
  30. Sodium Fluoride (2 revisions)
  31. Effect:Auditory misinterpretation (2 revisions)
  32. Problem:Delayed sleep phase (2 revisions)
  33. Dorzolamide (2 revisions)
  34. Effect:Increased bodily temperature (2 revisions)
  35. Problem:Obstructive sleep apnea in obesity (2 revisions)
  36. Garlic (2 revisions)
  37. Terbinafine (2 revisions)
  38. Effect:Temperature regulation suppression (2 revisions)
  39. Effect:Geometry (2 revisions)
  40. Ciclopirox (2 revisions)
  41. Effect:Cognitive dysphoria (2 revisions)
  42. Effect:Dysarthria (2 revisions)
  43. Brimonidine (2 revisions)
  44. Effect:Empathy, affection and sociability enhancement (2 revisions)
  45. Effect:Palpitations (2 revisions)
  46. Phenotype:CYP2D6 normal metabolizer (2 revisions)
  47. Ticagrelor (2 revisions)
  48. Effect:Disinhibition (2 revisions)
  49. USLegal:DEA Schedule IV (2 revisions)
  50. Levofloxacin (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:FewestRevisions"